It seems like an endless debate: When a patient does not respond to the first trial of an antidepressant, what should we do? Switch to something else? Augment with another agent? If the latter, how often should that augmenting agent be an atypical antipsychotic?

Dyslexia, a learning disability characterized by difficulty in reading skills, is highly prevalent, with rates between 5% and 17%. Treatments include non-medical interventions, which have limited success.